Candesartan ameliorates acute myocardial infarction in rats through inducible nitric oxide synthase, nuclear factor‑κB, monocyte chemoattractant protein‑1, activator protein‑1 and restoration of heat shock protein 72

Lin,Xuefeng; Wu,Min; Liu,Bo; Wang,Junkui; Guan,Gongchang; Ma,Aiqun; Zhang,Yong

doi:10.3892/mmr.2015.4432

Candesartan ameliorates acute myocardial infarction in rats through inducible nitric oxide synthase, nuclear factor‑κB, monocyte chemoattractant protein‑1, activator protein‑1 and restoration of heat shock protein 72

Authors:
- Xuefeng Lin
- Min Wu
- Bo Liu
- Junkui Wang
- Gongchang Guan
- Aiqun Ma
- Yong Zhang
View Affiliations

Affiliations: Department of Cardiovascular Medicine, First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China, Department of Endocrinology, Shaanxi Provincial People's Hospital, Third Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, Shaanxi 710068, P.R. China, First Department of Cardiology, Shaanxi Provincial People's Hospital, Third Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, Shaanxi 710068, P.R. China
Published online on: October 13, 2015 https://doi.org/10.3892/mmr.2015.4432
Pages: 8193-8200

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Candesartan, an angiotensin II type 1 receptor antagonist, has a variety of biological activities, including antioxidant, anti‑inflammatory and anticancer activities, with specific pharmacological effects. The present study investigated the mechanisms and protective effect of candesartan on acute myocardial infarction in rats. Male Wistar rats (8‑week‑old) were induced as a model of acute myocardial infarction and treated with candesartan (0.25 mg/kg) for 2 weeks. The present study first measured the activities of casein kinase (CK), the MB isoenzyme of creatine kinase (CK‑MB) and lactate dehydrogenase (LDH), the level of cardiac troponin T (cTnT) and infarct size. Subsequently, western blot analysis was performed to analyze the protein expression levels of inducible nitric oxide synthase (iNOS) and heat shock protein 72 (HSP72) in the rats. An enzyme linked immunosorbent assay was used to detect iNOS and nuclear factor‑κB (NF‑κB) activity. In addition, gene expression levels of monocyte chemotactic protein‑1 (MCP‑1) and activating protein‑1 (AP‑1) were determined using reverse transcription‑quantitative polymerase chain reaction analysis. Finally, the activities of caspase‑3 and caspase‑9 were examined using colorimetric assay kits. In the serum of the rat model of acute myocardial infarction, candesartan significantly increased the activities of CK, CK‑MB and LDH, and the level of cTnT. The infarction size was perfected by candesartan treatment. Candesartan significantly reduced the protein expression and activity of iNOS, the activity of NF‑κB p65, and the gene expression levels of MCP‑1 and AP‑1 in the rat model of acute myocardial infarction. Candesartan increased the protein expression of HSP‑72 in the acute myocardial infarction rat model. However, candesartan did not effect the levels of caspase‑3 or caspase‑9 in the rat model of acute myocardial infarction. These results suggested that candesartan ameliorates acute myocardial infarction in rats through iNOS, NF‑κB, MCP‑1 and AP‑1, and the restoration of HSP72.

View Figures

View References

1	Zhong J, He Y, Chen W, Shui X, Chen C and Lei W: Circulating microRNA-19a as a potential novel biomarker for diagnosis of acute myocardial infarction. Int J Mol Sci. 15:20355–20364. 2014. View Article : Google Scholar : PubMed/NCBI
2	Zhao YJ, Fu XH, Ma XX, Wang DY, Dong QL, Wang YB, Li W, Xing K, Gu XS and Jiang YF: Intracoronary fixed dose of nitro-6prusside via thrombus aspiration catheter for the prevention of the no-reflow phenomenon following primary percutaneous coronary intervention in acute myocardial infarction. Exp Ther Med. 6:479–484. 2013.PubMed/NCBI
3	Gui D, Li Y, Chen X, Gao D, Yang Y and Li X: HIF1 signaling pathway involving iNOS, COX2 and caspase-9 mediates the neuroprotection provided by erythropoietin in the retina of chronic ocular hypertension rats. Mol Med Rep. 11:1490–1496. 2015.
4	Liu X and Tao GZ: Effects of tirofiban on the reperfusion-related no-reflow in rats with acute myocardial infarction. J Geriatr Cardiol. 10:52–58. 2013.PubMed/NCBI
5	Zaitone SA and Abo-Gresha NM: Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: Role of iNOS and VEGF. Eur J Pharmacol. 691:134–142. 2012. View Article : Google Scholar : PubMed/NCBI
6	Xiong HY, Ma TT, Wu BT, Lin Y and Tu ZG: IL-12 regulates B7-H1 expression in ovarian cancer-associated macrophages by effects on NF-kB signalling. Asian Pac J Cancer Prev. 15:5767–5772. 2014. View Article : Google Scholar
7	Sui X and Gao C: Huperzine A ameliorates damage induced by acute myocardial infarction in rats through antioxidant, anti-apoptotic and anti-inflammatory mechanisms. Int J Mol Med. 33:227–233. 2014.
8	Qiao S, Xie H, Wang C, Wu X, Liu H and Liu C: Delayed anesthetic preconditioning protects against myocardial infarction via activation of nuclear factor-kB and upregulation of autophagy. J Anesth. 27:251–260. 2013. View Article : Google Scholar
9	Tang M, Wang Y, Han S, Guo S, Xu N and Guo J: Endogenous PGE(2) induces MCP-1 expression via EP4/p38 MAPK signaling in melanoma. Oncol Lett. 5:645–650. 2013.PubMed/NCBI
10	Martin T, Cardarelli PM, Parry GC, Felts KA and Cobb RR: Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1. Eur J Immunol. 27:1091–1097. 1997. View Article : Google Scholar : PubMed/NCBI
11	Valen G, Hansson GK, Dumitrescu A and Vaage J: Unstable angina activates myocardial heat shock protein 72, endothelial nitric oxide synthase, and transcription factors NFkappaB and AP-1. Cardiovasc Res. 47:49–56. 2000. View Article : Google Scholar : PubMed/NCBI
12	Xie SL, Wang JF, Nie RQ, Yuan WL, Li F and Lin YQ: The expression and significance of activator protein-1 and matrix metalloproteinases in the human heart post acute myocardial infarction. Zhonghua Nei Ke Za Zhi. 48:205–207. 2009.In Chinese. PubMed/NCBI
13	Tanonaka K, Toga W, Yoshida H, Furuhama K and Takeo S: Effect of long-term treatment with trandolapril on Hsp72 and Hsp73 induction of the failing heart following myocardial infarction. Br J Pharmacol. 134:969–976. 2001. View Article : Google Scholar : PubMed/NCBI
14	Marunouchi T, Araki M, Murata M, Takagi N and Tanonaka K: Possible involvement of HSP90-HSF1 multichaperone complex in impairment of HSP72 induction in the failing heart following myocardial infarction in rats. J Pharmacol Sci. 123:336–346. 2013. View Article : Google Scholar : PubMed/NCBI
15	Gholitabar S and Roshan VD: Effect of treadmill exercise and Ferula gummosa on myocardial HSP72, vascular function, and antioxidant defenses in spontaneously hypertensive rats. Clin Exp Hypertens. 35:347–354. 2013. View Article : Google Scholar
16	Songur CM, Songur MO, Kocabeyoglu SS and Basgut B: Effects of the AT1 receptor blocker candesartan on myocardial ischemia/reperfusion in isolated rat hearts. Heart Surg Forum. 17:E263–E268. 2014. View Article : Google Scholar : PubMed/NCBI
17	Jusufovic M, Sandset EC, Bath PM and Berge E; Scandinavian Candesartan Acute Stroke Trial Study Group: Blood pressure-lowering treatment with candesartan in patients with acute hemorrhagic stroke. Stroke. 45:3440–3442. 2014. View Article : Google Scholar : PubMed/NCBI
18	Taniguchi Y, Takahashi N, Fukui A, Nagano-Torigoe Y, Thuc LC, Teshima Y, Shinohara T, Wakisaka O, Ooie T, Murozono Y, et al: Candesartan restored cardiac Hsp72 expression and tolerance against reperfusion injury in hereditary insulin-resistant rats. Cardiovasc Res. 92:439–448. 2011. View Article : Google Scholar : PubMed/NCBI
19	Marx JO, Brice AK, Boston RC and Smith AL: Incidence rates of spontaneous disease in laboratory mice used at a large biomedical research institution. J Am Assoc Lab Anim Sci. 52:782–791. 2013.PubMed/NCBI
20	Faria Tde O, Baldo MP, Simões MR, Pereira RB, Mill JG, Vassallo DV and Stefanon I: Body weight loss after myocardial infarction in rats as a marker of early heart failure development. Arch Med Res. 42:274–280. 2011. View Article : Google Scholar : PubMed/NCBI
21	Zeng KW, Zhang T, Fu H, Liu GX and Wang XM: Schisandrin B exerts anti-neuroinflammatory activity by inhibiting the Toll-like receptor 4-dependent MyD88/IKK/NF-kB signaling pathway in lipopolysaccharide-induced microglia. Eur J Pharmacol. 692:29–37. 2012. View Article : Google Scholar : PubMed/NCBI
22	Hoda MN, Li W, Ahmad A, Ogbi S, Zemskova MA, Johnson MH, Ergul A, Hill WD, Hess DC and Sazonova IY: Sex-independent neuroprotection with minocycline after experimental thrombo-embolic stroke. Exp Transl Stroke Med. 3:162011. View Article : Google Scholar
23	Hoda MN, Siddiqui S, Herberg S, Periyasamy-Thandavan S, Bhatia K, Hafez SS, Johnson MH, Hill WD, Ergul A, Fagan SC and Hess DC: Remote ischemic perconditioning is effective alone and in combination with intravenous tissue-type plasminogen activator in murine model of embolic stroke. Stroke. 43:2794–2799. 2012. View Article : Google Scholar : PubMed/NCBI
24	Lv P, Zhou M, He J, Meng W, Ma X, Dong S, Meng X, Zhao X, Wang X and He F: Circulating miR-208b and miR-34a are associated with left ventricular remodeling after acute myocardial infarction. Int J Mol Sci. 15:5774–5788. 2014. View Article : Google Scholar : PubMed/NCBI
25	Lee SR, Noh SJ, Pronto JR, Jeong YJ, Kim HK, Song IS, Xu Z, Kwon HY, Kang SC, Sohn EH, et al: The critical roles of zinc: Beyond impact on myocardial signaling. Korean J Physiol Pharmacol. 19:389–399. 2015. View Article : Google Scholar : PubMed/NCBI
26	Suzuki H, Kusuyama T, Omori Y, Soda T, Tsunoda F, Sato T, Shoji M, Iso Y, Kondo T, Koba S, et al: Inhibitory effect of candesartan cilexetil on left ventricular remodeling after myocardial infarction. Int Heart J. 47:715–725. 2006. View Article : Google Scholar : PubMed/NCBI
27	Jiang P, Li C, Xiang Z and Jiao B: Tanshinone IIA reduces the risk of Alzheimer's disease by inhibiting iNOS, MMP-2 and NF-kBp65 transcription and translation in the temporal lobes of rat models of Alzheimer's disease. Mol Med Rep. 10:689–694. 2014.PubMed/NCBI
28	Lee KF, Chen JH, Teng CC, Shen CH, Hsieh MC, Lu CC, Lee KC, Lee LY, Chen WP, Chen CC, et al: Protective effects of Hericium erinaceus mycelium and its isolated erinacine A against ischemia-injury-induced neuronal cell death via the inhibition of iNOS/p38 MAPK and nitrotyrosine. Int J Mol Sci. 15:15073–15089. 2014. View Article : Google Scholar : PubMed/NCBI
29	Bian SH, Yu MY and Geng Q: The relationship between the plasma concentration of urotension II (U II) and NO, NOS in spontaneous hypertensive rats and influence of candesartan. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 25:194–195. 2632009.In Chinese.
30	Miller AG, Tan G, Binger KJ, Pickering RJ, Thomas MC, Nagaraj RH, Cooper ME and Wilkinson-Berka JL: Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function. Diabetes. 59:3208–3215. 2010. View Article : Google Scholar : PubMed/NCBI
31	Wang Y, Ma W and Zheng W: Deguelin, a novel anti-tumorigenic agent targeting apoptosis, cell cycle arrest and anti-angiogenesis for cancer chemoprevention. Mol Clin Oncol. 1:215–219. 2013.
32	Korkmaz S, Atmanli A, Li S, Radovits T, Hegedűs P, Barnucz E, Hirschberg K, Loganathan S, Yoshikawa Y, Yasui H, et al: Superiority of zinc complex of acetylsalicylic acid to acetylsalicylic acid in preventing postischemic myocardial dysfunction. Exp Biol Med (Maywood). 240:1247–1255. 2015. View Article : Google Scholar
33	Basso C, Calabrese F, Angelini A, Carturan E and Thiene G: Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease. Heart Fail Rev. 18:673–681. 2013. View Article : Google Scholar
34	Hadi NR, Yousif NG, Abdulzahra MS, Mohammad BI, Al-Amran FG, Majeed ML and Yousif MG: Role of NF-κβ and oxidative pathways in atherosclerosis: Cross-talk between dyslipidemia and candesartan. Cardiovasc Ther. 31:381–387. 2013. View Article : Google Scholar : PubMed/NCBI
35	Ishrat T, Pillai B, Ergul A, Hafez S and Fagan SC: Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic stroke. Neurochem Res. 38:2668–2677. 2013. View Article : Google Scholar : PubMed/NCBI
36	Zhao LQ, Huang JL, Yu Y, Lu Y, Fu LJ, Wang JL, Wang YD and Yu C: Candesartan inhibits LPS-induced expression increase of toll-like receptor 4 and downstream inflammatory factors likely via angiotensin II type 1 receptor independent pathway in human renal tubular epithelial cells. Sheng Li Xue Bao. 65:623–630. 2013.PubMed/NCBI
37	Tharaux PL, Chatziantoniou C, Fakhouri F and Dussaule JC: Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway. Hypertension. 36:330–336. 2000. View Article : Google Scholar : PubMed/NCBI
38	Traister A, Walsh M, Aafaqi S, Lu M, Dai X, Henkleman MR, Momen A, Zhou YQ, Husain M, Arab S, et al: Mutation in integrin-linked kinase (ILK(R211A)) and heat-shock protein 70 comprise a broadly cardioprotective complex. PLoS One. 8:e773312013. View Article : Google Scholar : PubMed/NCBI
39	Yadav HN, Singh M and Sharma PL: Pharmacological inhibition of GSK-3β produces late phase of cardioprotection in hyperlipidemic rat: Possible involvement of HSP 72. Mol Cell Biochem. 369:227–233. 2012. View Article : Google Scholar : PubMed/NCBI
40	Torrente MP and Shorter J: The metazoan protein disaggregase and amyloid depolymerase system: Hsp110, Hsp70, Hsp40, and small heat shock proteins. Prion. 7:457–463. 2013. View Article : Google Scholar
41	Chen C, Du P and Wang J: Paeoniflorin ameliorates acute myocardial infarction of rats by inhibiting inflammation and inducible nitric oxide synthase signaling pathways. Mol Med Rep. 12:3937–3943. 2015.PubMed/NCBI
42	Nural-Guvener HF, Zakharova L, Nimlos J, Popovic S, Mastroeni D and Gaballa MA: HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation. Fibrogenesis Tissue Repair. 7:102014. View Article : Google Scholar : PubMed/NCBI
43	Moudgil R, Musat-Marcu S, Xu Y, Kumar D and Jugdutt BI: Increased AT2R protein expression but not increased apoptosis during cardioprotection induced by AT1R blockade. Can J Cardiol. 18:873–883. 2002.PubMed/NCBI